(Reuters) -President-elect Donald Trump met with the chief executives of U.S. drugmakers Pfizer (NYSE:) and Eli Lilly (NYSE:) in addition to trade lobbying group PhRMA on Wednesday evening, Axios reported on Thursday.
Anti-vaccine activist Robert F. Kennedy Jr., Trump’s choose to steer america’ prime well being company, was additionally current on the assembly, in line with the report.
A PhRMA spokesperson confirmed that its president and CEO, Stephen Ubl, was current on the dinner, however declined to share every other particulars.
Eli Lilly and Pfizer didn’t instantly reply to Reuters’ requests for remark.
Trump and the corporate executives mentioned how the private and non-private sectors can collaborate on discovering cures for most cancers, amongst different subjects, on the assembly, which came about at Mar-a-Lago, in line with the report.
Mar-a-Lago is the Florida mansion and personal membership that Trump calls residence.
Trump’s incoming chief of workers, Susie Wiles, additionally attended the assembly, the report added.
